Atractylodin Ameliorates Bleomycin-Induced Pulmonary Inflammation and Fibrosis in Mice

[1]  Lei Sun,et al.  Naringin regulates endoplasmic reticulum stress and mitophagy through the ATF3/PINK1 signaling axis to alleviate pulmonary fibrosis , 2023, Naunyn-Schmiedeberg's Archives of Pharmacology.

[2]  W. Dong,et al.  C-type lectin Mincle initiates IL-17-mediated inflammation in acute exacerbations of idiopathic pulmonary fibrosis. , 2023, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[3]  Xiaofeng Wu,et al.  Fluvoxamine alleviates bleomycin-induced lung fibrosis via regulating the cGAS-STING pathway. , 2022, Pharmacological research.

[4]  Yang Li,et al.  Puerarin protects fibroblasts against mechanical stretching injury through Nrf2/TGF-β1 signaling pathway , 2022, International Urogynecology Journal.

[5]  E. Chen,et al.  IL-10/IL-10 receptor 1 pathway promotes the viability and collagen synthesis of pulmonary fibroblasts originated from interstitial pneumonia tissues , 2022, Experimental and therapeutic medicine.

[6]  Ying-Zi Qi,et al.  Atractylodin induces oxidative stress‐mediated apoptosis and autophagy in human breast cancer MCF‐7 cells through inhibition of the P13K/Akt/mTOR pathway , 2022, Journal of biochemical and molecular toxicology.

[7]  Zhenhua Yang,et al.  Idiopathic Pulmonary Fibrosis: An Update on Pathogenesis , 2022, Frontiers in Pharmacology.

[8]  G. Lv,et al.  Preparation, characterization, and bioactivity evaluation of oligosaccharides from Atractylodes lancea (Thunb.) DC. , 2021, Carbohydrate Polymers.

[9]  E. Clini,et al.  Molecular Mechanisms and Cellular Contribution from Lung Fibrosis to Lung Cancer Development , 2021, International journal of molecular sciences.

[10]  Shih-Chao Lin,et al.  Atractylodin Suppresses TGF-β-Mediated Epithelial-Mesenchymal Transition in Alveolar Epithelial Cells and Attenuates Bleomycin-Induced Pulmonary Fibrosis in Mice , 2021, International journal of molecular sciences.

[11]  Kang Xu,et al.  Atractylodin Attenuates Dextran Sulfate Sodium-Induced Colitis by Alleviating Gut Microbiota Dysbiosis and Inhibiting Inflammatory Response Through the MAPK Pathway , 2021, Frontiers in Pharmacology.

[12]  T. Maher,et al.  Enhanced IL-1β Release Following NLRP3 and AIM2 Inflammasome Stimulation Is Linked to mtROS in Airway Macrophages in Pulmonary Fibrosis , 2021, Frontiers in Immunology.

[13]  Yong-bin Hu,et al.  TGF-β1: Gentlemanly orchestrator in idiopathic pulmonary fibrosis (Review) , 2021, International journal of molecular medicine.

[14]  A. Dhingra,et al.  Natural products: A lead for drug discovery and development , 2021, Phytotherapy research : PTR.

[15]  Yvette N. Lamb.  Nintedanib: A Review in Fibrotic Interstitial Lung Diseases , 2021, Drugs.

[16]  M. Zheng,et al.  High-Expressed Macrophage Scavenger Receptor 1 Predicts Severity Clinical Outcome in Transplant Patient in Idiopathic Pulmonary Fibrosis Disease , 2021, Journal of immunology research.

[17]  Ho-Geun Yoon,et al.  Aucuparin Suppresses Bleomycin-Induced Pulmonary Fibrosis Via Anti-Inflammatory Activity. , 2021, Journal of medicinal food.

[18]  Tinghong Ye,et al.  The role of natural products in the prevention and treatment of pulmonary fibrosis: a review. , 2021, Food & function.

[19]  Shuqi Zhao,et al.  Atractylodin may induce ferroptosis of human hepatocellular carcinoma cells , 2021, Annals of translational medicine.

[20]  A. Szopa,et al.  Biological Activities of Natural Products , 2020, Molecules.

[21]  V. Thannickal,et al.  Oxidative Stress in Pulmonary Fibrosis. , 2020, Comprehensive Physiology.

[22]  D. Shitrit,et al.  TGF-β pathway activation by idiopathic pulmonary fibrosis (IPF) fibroblast derived soluble factors is mediated by IL-6 trans-signaling , 2020, Respiratory Research.

[23]  M. Corradi,et al.  Idiopathic pulmonary fibrosis and occupational risk factors , 2019, La Medicina del lavoro.

[24]  Meng Li,et al.  Protective effects of GHK-Cu in bleomycin-induced pulmonary fibrosis via anti-oxidative stress and anti-inflammation pathways. , 2019, Life sciences.

[25]  Feng Qian,et al.  Baccatin III ameliorates bleomycin-induced pulmonary fibrosis via suppression of TGF-β1 production and TGF-β1-induced fibroblast differentiation. , 2019, International immunopharmacology.

[26]  Y. Qiu,et al.  A New Use for an Old Drug: Carmofur Attenuates Lipopolysaccharide (LPS)-Induced Acute Lung Injury via Inhibition of FAAH and NAAA Activities , 2019, Front. Pharmacol..

[27]  Geng Chen,et al.  Atractylodin ameliorates lipopolysaccharide and d-galactosamine-induced acute liver failure via the suppression of inflammation and oxidative stress. , 2019, International immunopharmacology.

[28]  M. Confalonieri,et al.  Epithelial–Mesenchymal Transition in the Pathogenesis of Idiopathic Pulmonary Fibrosis , 2019, Medicina.

[29]  T. Kinoshita,et al.  Molecular Mechanisms of Pulmonary Fibrogenesis and Its Progression to Lung Cancer: A Review , 2019, International journal of molecular sciences.

[30]  M. Kool,et al.  Inflammation and immunity in IPF pathogenesis and treatment. , 2019, Respiratory medicine.

[31]  H. Cai,et al.  Loss of PTEN induces lung fibrosis via alveolar epithelial cell senescence depending on NF‐κB activation , 2018, Aging cell.

[32]  C. Zuo,et al.  A Chinese Traditional Therapy for Bleomycin-Induced Pulmonary Fibrosis in Mice , 2018, Canadian respiratory journal.

[33]  A. Mangoni,et al.  Oxidative stress-linked biomarkers in idiopathic pulmonary fibrosis: a systematic review and meta-analysis. , 2018, Biomarkers in medicine.

[34]  Chuanzhou Bian,et al.  Atractylodin attenuates lipopolysaccharide-induced acute lung injury by inhibiting NLRP3 inflammasome and TLR4 pathways. , 2018, Journal of pharmacological sciences.

[35]  D. Sheppard,et al.  TGF-β1 Signaling and Tissue Fibrosis. , 2018, Cold Spring Harbor perspectives in biology.

[36]  Yabing Chen,et al.  TNF‐α‐induced NF‐κB activation promotes myofibroblast differentiation of LR‐MSCs and exacerbates bleomycin‐induced pulmonary fibrosis , 2018, Journal of cellular physiology.

[37]  L. Richeldi,et al.  Idiopathic pulmonary fibrosis: pathogenesis and management , 2018, Respiratory Research.

[38]  Y. Son,et al.  A neuropeptide, Substance-P, directly induces tissue-repairing M2 like macrophages by activating the PI3K/Akt/mTOR pathway even in the presence of IFNγ , 2017, Scientific Reports.

[39]  J. Christman,et al.  AKT2 Regulates Pulmonary Inflammation and Fibrosis via Modulating Macrophage Activation , 2017, The Journal of Immunology.

[40]  A. Hajari Case,et al.  Clinical use of nintedanib in patients with idiopathic pulmonary fibrosis , 2017, BMJ Open Respiratory Research.

[41]  Yuan Lin,et al.  Ameliorative effects of atractylodin on intestinal inflammation and co-occurring dysmotility in both constipation and diarrhea prominent rats , 2016, The Korean journal of physiology & pharmacology : official journal of the Korean Physiological Society and the Korean Society of Pharmacology.

[42]  A. Gemma,et al.  Pirfenidone inhibits fibrocyte accumulation in the lungs in bleomycin-induced murine pulmonary fibrosis , 2014, Respiratory Research.

[43]  Robert Alexander,et al.  Ex vivo micro-computed tomography analysis of bleomycin-induced lung fibrosis for preclinical drug evaluation , 2013, European Respiratory Journal.

[44]  Oliver Eickelberg,et al.  The impact of TGF-β on lung fibrosis: from targeting to biomarkers. , 2012, Proceedings of the American Thoracic Society.

[45]  F. Martinez,et al.  Recent advances in idiopathic pulmonary fibrosis. , 2007, Chest.

[46]  C. Agostini,et al.  Chemokine/cytokine cocktail in idiopathic pulmonary fibrosis. , 2006, Proceedings of the American Thoracic Society.

[47]  T. Wynn.  IL-13 effector functions. , 2003, Annual review of immunology.

[48]  J. Bertoglio,et al.  Induction of the IL-13 receptor α2-chain by IL-4 and IL-13 in human keratinocytes: involvement of STAT6, ERK and p38 MAPK pathways , 2001, Oncogene.